Skip to Content

par 164 (Benztropine 0.5 mg)

Pill imprint par 164 has been identified as Benztropine mesylate 0.5 mg.

Benztropine is used in the treatment of extrapyramidal reaction; hyperhidrosis; parkinson's disease and belongs to the drug class anticholinergic antiparkinson agents. FDA has not classified the drug for risk during pregnancy. Benztropine 0.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Benztropine mesylate 0.5 mg par 164  Front
Benztropine mesylate 0.5 mg par 164  Back
Benztropine mesylate 0.5 mg par 164
Benztropine mesylate
par 164
0.5 mg
6.00 mm
Prescription only
Drug Class:
Anticholinergic antiparkinson agents
Pregnancy Category:
N - Not classified
CSA Schedule:
N - Not a controlled drug
Par Pharmaceutical Inc.
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00182-1299 Goldline Laboratories Inc
00904-1055 Major Pharmaceuticals
63739-0033 McKesson Packaging Services
68115-0826 Dispensexpress Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.